IMU 0.00% 4.9¢ imugene limited

Ann: Bile Tract Cancer Study Opens after MAST High Dose Clearance, page-31

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 2,012 Posts.
    lightbulb Created with Sketch. 615
    The big question is how long will it take to find 10 bile duct cancer patients who have failed at least 2 prior lines of treatment across 10 sites in the US and a few here in Australia?
    And we are about to present at the very niche cholangiocarcinoma conference in the US. Magnificent marketing opportunity and hopefully providing a glimmer of hope for 10 very fortunate souls. This could all move very quickly now. Perhaps one more dose escalation just to be certain. This is truely exceptional news.
 
watchlist Created with Sketch. Add IMU (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.